Professor Michael Reade

Professor and Deputy Head of School

Medical School (Office & AME)
Faculty of Medicine
m.reade@uq.edu.au
+61 7 336 55114

Overview

Professor Reade is Director of the Greater Brisbane Clinical School and Professor of Military Medicine and Surgery at UQ. The Greater Brisbane Clinical School comprises all the Brisbane teaching hospitals of the University of Queensland along with the preclinical teaching resources of the St Lucia campus and the General Practice Clinical Unit. A specialist intensive care physician, anaesthetist and clinician-researcher, he also leads a program of research relevant to military trauma medicine and surgery that holds equal promise for severely injured civilian trauma patients.

After clinical training in anaesthetics and intensive care medicine in Sydney, Melbourne, Oxford and Pittsburgh, a doctorate in the molecular pathogenesis of nitric oxide production in human septic shock from the University of Oxford and a postdoctoral research fellowship in clinical trials and epidemiology from the University of Pittsburgh, Michael returned to Australia as Associate Professor of Intensive Care Medicine at the Austin Hospital & the University of Melbourne in 2007. Michael held faculty appointments at the University of Oxford (where he taught physiology), the University of Pittsburgh (where he was an Instructor in critical care), and currently holds adjunct or honorary appointments at the University of London, the US Uniformed Services University of the Health Sciences, the University of Melbourne and Monash University. He has supervised postgraduate students in basic, applied and clinical research, and is a Fellow of the Higher Education Academy of the United Kingdom.

In parallel with his academic and clinical work, Michael served in the Australian Army Reserve until his appointment to the full-time ADF Chair in 2011. He was commissioned as a General Service Officer in the Australian Army in 1990, and prior to his appointment to UQ had deployed to Bosnia and Kosovo (on attachment to the British Airborne Brigade), Timor, the Solomon Islands and Afghanistan. In 2013 he commanded the Australian Specialist Health Group at the NATO ISAF Role 3 Hospital in Kandahar, Afghanistan, and in 2015 in Iraq he was the first Director of Clinical Services of the ADF hospital deployed in support of Operation Inherent Resolve. He deployed again to Iraq in 2016 and 2017. From 2015-2018 he was the Director of Clinical Services of the Australian Regular Army's only field hospital. In 2017 he led this unit to become the first ever ADF hospital accredited by the Royal Australasian College of Surgeons Trauma Verification Program. He was recognised for this service by appointment as a Member in the Military Division of the Order of Australia in the 2019 Queen's Birthday Honours List. From 2019-2022 on promotion to Brigadier he was appointed Director General Health Reserve - Army, responsible for technical regulation of specialist medical, nursing and allied health support. He remains a senior clinical advisor to Joint Health Command of the Australian Defence Force.

Professor Reade's clinical research focusses on treatments for exsanguinating haemorrhage, improving trauma systems, and preventing and treating acute cognitive impairment (such as that which results from traumatic brain injury). He is the Chief Investigator in an NHMRC-funded clinical trial of cyropreserved (frozen) platelets, a technology which holds equal promise to military and civilian trauma patients, particularly those in smaller hospitals. He is also a Chief Investigator in NHMRC-funded multicentre clinical trials of tranexamic acid and fibrinogen concentrate (drugs thought to reduce mortality from traumatic bleeding), the effect of erythropoietin on inflammation and mortality after severe trauma, a novel anti-delirium strategy for use in critically ill patients, and an advanced MRI/biomarker study in traumatic brain injury. He has active research collaborations with Australian Red Cross Lifeblood, the National Trauma Research Institute, the Australian and New Zealand Intensive Care Research Centre at Monash University, the ANZICS Clinical Trials Group and the ANZCA Clinical Trials Network.

Professor Reade is also developing a research programme focussed on trauma systems design, in collaboration with colleagues at the Jamieson Trauma Institute on the Royal Brisbane and Women's Hospital campus, Australian state ambulance services and the US and UK armed forces, aiming (for example) to optimise the allocation of prehospital and hospital resources in the management of life-threatening trauma.

Professor Reade currently supervises 13 postgraduate students (including 4 PhD students) and one postdoctoral research fellow, most of whom are Defence Force officers. He holds or has held research grants totalling >A$40M, has published >200 peer-reviewed papers and delivered >400 lectures at national and international conferences. From 2019-2021, Professor Reade was President of the Australasian Trauma Society.

Research Interests

  • Trauma
  • Haemorrhage
  • Coagulopathy
  • Trauma systems
  • Delirium

Qualifications

  • Associate Fellow, Royal Australasian College of Medical Administrators, Royal Australasian College of Medical Administrators
  • Fellow, Higher Education Academy, Higher Education Academy
  • College of Intensive Care Medicine, College of Intensive Care Medicine
  • Australian and New Zealand College of Anaesthetists, Australian and New Zealand College of Anaesthetists
  • Australian Institute of Company Directors, Australian Institute of Company Directors
  • Doctoral Diploma, University of Sydney
  • Masters (Coursework) of Public Health, University of Pittsburgh
  • Doctor of Philosophy, University of Oxford
  • Bachelor of Medicine and Surgery and Medical Science, University of Sydney
  • Bachelor of Science, University of Sydney

Publications

  • Mitra, Biswadev, Jorgensen, Margaret, Reade, Michael C, Keegan, Anastazia, Holley, Anthony, Farmer, Shannon, Harvey, Nichole, Winearls, James, Parr, Michael, French, Craig J and for the Clinical and Consumer Reference Group for the Update of Patient Blood Management Guidelines (Module 1: Critical Bleeding/Massive Transfusion) (2024). Patient blood management guideline for adults with critical bleeding. Medical Journal of Australia. doi: 10.5694/mja2.52212

  • Walsh, Timothy Simon, Aitken, Leanne M, McKenzie, Cathrine A, Boyd, Julia, Macdonald, Alix, Giddings, Annabel, Hope, David, Norrie, John, Weir, Christopher, Parker, Richard Anthony, Lone, Nazir I, Emerson, Lydia, Kydonaki, Kalliopi, Creagh-Brown, Benedict, Morris, Stephen, McAuley, Daniel Francis, Dark, Paul, Wise, Matt P, Gordon, Anthony C, Perkins, Gavin, Reade, Michael, Blackwood, Bronagh, MacLullich, Alasdair, Glen, Robert and Page, Valerie J (2023). Alpha 2 agonists for sedation to produce better outcomes from critical illness (A2B Trial): protocol for a multicentre phase 3 pragmatic clinical and cost-effectiveness randomised trial in the UK. BMJ Open, 13 (12) e078645, 1-11. doi: 10.1136/bmjopen-2023-078645

  • Cotta, Menino O., Roberts, Jason A. and Reade, Michael C. (2023). Comment: Is off-label medication use in the ICU a problem?. Critical Care, 27 (1) 288, 288. doi: 10.1186/s13054-023-04546-y

View all Publications

Supervision

View all Supervision

Publications

Book Chapter

  • Flint, A. W., Winearls, J. and Reade, M. C. (2023). The Most Important Questions in the Current Practice of Transfusion of Critically Bleeding Patients. Annual Update in Intensive Care and Emergency Medicine 2023. (pp. 339-353) Cham: Springer Nature Switzerland. doi: 10.1007/978-3-031-23005-9_25

  • Mahoney, A. J. and Reade, M. C. (2020). Evaluating quality in trauma systems. Annual update in intensive care and emergency medicine 2020. (pp. 397-412) edited by Jean-Louis Vincent. Cham, Switzerland: Springer. doi: 10.1007/978-3-030-37323-8_31

  • Liu, D. and Reade, M. C. (2018). Central α2-adrenoreceptor agonists in intensive care. Annual update in intensive care and emergency medicine. (pp. 561-577) edited by Jean-Louis Vincent. Basel, Switzerland: Springer, Cham. doi: 10.1007/978-3-319-73670-9_42

  • Mahoney, A., Vassiliadis, J. and Reade, M. C. (2017). Making the Best Use of Simulation Training in Critical Care Medicine. Annual Update in Intensive Care and Emergency Medicine. (pp. 477-492) Cham, Switzerland: Springer. doi: 10.1007/978-3-319-51908-1_37

  • Kirkman, Emrys and Reade, Michael C. (2016). Management of blast related injuries. Trauma and combat critical care in clinical practice. (pp. 225-243) edited by Sam D. Hutchings. Cham, Switzerland: Springer International Publishing. doi: 10.1007/978-3-319-28758-4_10

  • Reade, Michael C. (2016). Thoracic trauma and management of ventilation in the critically injured patient. Trauma and combat critical care in clinical practice. (pp. 189-224) edited by Sam D. Hutchings. Cham, Switzerland: Springer International Publishing. doi: 10.1007/978-3-319-28758-4_9

  • Reade, Michael C. and Thomas, Peter D (Toby) (2013). Ballistic injury. Oh's Intensive Care Manual, Seventh Edition. (pp. 861-870) Elsevier. doi: 10.1016/B978-0-7020-4762-6.00085-0

  • Reade, M. C. and Holley, A. D. (2012). A new understanding of coagulopathy in trauma: potential therapeutic implications. Annual update in intensive care and emergency medicine 2012. (pp. 689-698) edited by Jean-Louis Vincent. Berlin, Germany: Springer. doi: 10.1007/978-3-642-25716-2_62

  • Reade, Michael C. and Angus, Derek C. (2009). Epidemiology of Sepsis and Non-Infectious SIRS. Sepsis and Non-Infectious Systemic Inflammation: From Biology to Critical Care. (pp. 13-39) Weinheim, Germany: Wiley-VCH Verlag GmbH & Co. KGaA. doi: 10.1002/9783527626151.ch2

  • Reade, Michael C. and Story, David A. (2008). Respiratory Acid-Base Disorders. Critical Care Nephrology, Second Edition. (pp. 625-630) Elsevier. doi: 10.1016/B978-1-4160-4252-5.50125-8

  • Reade, Michael C. and Story, David A. (2008). Respiratory Acid-Base Physiology. Critical Care Nephrology, Second Edition. (pp. 592-596) Elsevier. doi: 10.1016/B978-1-4160-4252-5.50118-0

  • Reade, M. C., Milbrandt, E. B. and Angus, D. C. (2007). The impact of chronic disease on response to infection. Intensive Care Medicine: Annual Update 2007. (pp. 197-207) New York, NY: Springer New York. doi: 10.1007/978-0-387-49518-7_18

Journal Article

Conference Publication

Grants (Administered at UQ)

PhD and MPhil Supervision

Current Supervision

  • Doctor Philosophy — Principal Advisor

  • Doctor Philosophy — Principal Advisor

  • Doctor Philosophy — Associate Advisor

Completed Supervision